179 related articles for article (PubMed ID: 27094978)
1. Levels of human platelet-derived soluble CD40 ligand depend on haplotypes of CD40LG-CD40-ITGA2.
Aloui C; Prigent A; Tariket S; Sut C; Fagan J; Cognasse F; Chakroun T; Garraud O; Laradi S
Sci Rep; 2016 Apr; 6():24715. PubMed ID: 27094978
[TBL] [Abstract][Full Text] [Related]
2. The proinflammatory mediator CD40 ligand is increased in the metabolic syndrome and modulated by adiponectin.
Natal C; Restituto P; Iñigo C; Colina I; Díez J; Varo N
J Clin Endocrinol Metab; 2008 Jun; 93(6):2319-27. PubMed ID: 18349065
[TBL] [Abstract][Full Text] [Related]
3. Are polymorphisms of the immunoregulatory factor CD40LG implicated in acute transfusion reactions?
Aloui C; Sut C; Prigent A; Fagan J; Cognasse F; Granados-Herbepin V; Touraine R; Pozzetto B; Aouni M; Fendri C; Hassine M; Chakroun T; Jemni-Yacoub S; Garraud O; Laradi S
Sci Rep; 2014 Nov; 4():7239. PubMed ID: 25430087
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD40 ligand impairs the anti-platelet function of peripheral blood angiogenic outgrowth cells via increased production of reactive oxygen species.
Bou Khzam L; Hachem A; Zaid Y; Boulahya R; Mourad W; Merhi Y
Thromb Haemost; 2013 May; 109(5):940-7. PubMed ID: 23426185
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of platelet glycoprotein Ia and the risk for premature myocardial infarction: effects on the release of sCD40L during the acute phase of premature myocardial infarction.
Antoniades C; Tousoulis D; Vasiliadou C; Stefanadi E; Marinou K; Stefanadis C
J Am Coll Cardiol; 2006 May; 47(10):1959-66. PubMed ID: 16697311
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome.
Mälarstig A; Lindahl B; Wallentin L; Siegbahn A
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1667-73. PubMed ID: 16627810
[TBL] [Abstract][Full Text] [Related]
7. Association between CD40 polymorphisms and systemic lupus erythematosus and correlation between soluble CD40 and CD40 ligand levels in the disease: a meta-analysis.
Bae SC; Lee YH
Lupus; 2019 Oct; 28(12):1452-1459. PubMed ID: 31570051
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis.
Teruel M; Simeon CP; Broen J; Vonk MC; Carreira P; Camps MT; García-Portales R; Delgado-Frías E; Gallego M; Espinosa G; ; Beretta L; Airó P; Lunardi C; Riemekasten G; Witte T; Krieg T; Kreuter A; Distler JH; Hunzelmann N; Koeleman BP; Voskuyl AE; Schuerwegh AJ; González-Gay MA; Radstake TR; Martin J
Arthritis Res Ther; 2012 Jun; 14(3):R154. PubMed ID: 22731751
[TBL] [Abstract][Full Text] [Related]
9. [Association between inflammatory cytokine CD40 gene polymorphism and risk of acute coronary syndrome].
Tian CX; Li Y; Wang M; Xia ZE; Li XY; Huang CX
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Mar; 36(3):199-204. PubMed ID: 19099972
[TBL] [Abstract][Full Text] [Related]
10. Evidence for involvement of the CD40/CD40L system in post-stroke epilepsy.
Zhang B; Chen M; Yang H; Wu T; Song C; Guo R
Neurosci Lett; 2014 May; 567():6-10. PubMed ID: 24657679
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions.
Riondino S; Martini F; La Farina F; Spila A; Guadagni F; Ferroni P
Clin Biochem; 2010 May; 43(7-8):666-70. PubMed ID: 20060822
[TBL] [Abstract][Full Text] [Related]
12. Involvement of nuclear factor κB in platelet CD40 signaling.
Hachem A; Yacoub D; Zaid Y; Mourad W; Merhi Y
Biochem Biophys Res Commun; 2012 Aug; 425(1):58-63. PubMed ID: 22820189
[TBL] [Abstract][Full Text] [Related]
13. Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients.
Fernández Bello I; Álvarez MT; López-Longo FJ; Arias-Salgado EG; Martín M; Jiménez-Yuste V; Rodríguez de la Rúa A; Butta NV
Thromb Haemost; 2012 Jan; 107(1):88-98. PubMed ID: 22116092
[TBL] [Abstract][Full Text] [Related]
14. [Association of SNP of leukocyte differentiation antigen-CD40 gene and its serum level with ischemic stroke].
Chen J; Huang H; Yuan Q; Luo H; Xiang Y; Wang C; Meng L; Wei Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Mar; 50(3):239-43. PubMed ID: 26957242
[TBL] [Abstract][Full Text] [Related]
15. Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products.
Varo N; Libby P; Nuzzo R; Italiano J; Doria A; Schönbeck U
Diab Vasc Dis Res; 2005 May; 2(2):81-7. PubMed ID: 16308911
[TBL] [Abstract][Full Text] [Related]
16. Analysis of serum soluble CD40 ligand (sCD40L) in the patients undergoing allogeneic stem cell transplantation: platelet is a major source of serum sCD40L.
Nagasawa M; Zhu Y; Isoda T; Tomizawa D; Itoh S; Kajiwara M; Morio T; Nonoyama S; Shimizu N; Mizutani S
Eur J Haematol; 2005 Jan; 74(1):54-60. PubMed ID: 15613107
[TBL] [Abstract][Full Text] [Related]
17. The
Liu ZL; Hu J; Xiao XF; Peng Y; Zhao SP; Xiao XZ; Yang MS
Biomed Res Int; 2018; 2018():7497314. PubMed ID: 29780830
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil CD40 enhances platelet-mediated inflammation.
Vanichakarn P; Blair P; Wu C; Freedman JE; Chakrabarti S
Thromb Res; 2008; 122(3):346-58. PubMed ID: 18289643
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine modulates the CD40/CD40L system.
Prontera C; Martelli N; Evangelista V; D'Urbano E; Manarini S; Recchiuti A; Dragani A; Passeri C; Davì G; Romano M
J Am Coll Cardiol; 2007 Jun; 49(22):2182-90. PubMed ID: 17543638
[TBL] [Abstract][Full Text] [Related]
20. Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation.
Lee SP; Ataga KI; Orringer EP; Phillips DR; Parise LV
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1626-31. PubMed ID: 16601237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
